SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern
- David W. Hawman
- , Kimberly Meade-White
- , Jacob Archer
- , Shanna S. Leventhal
- , Drew Wilson
- , Carl Shaia
- , Samantha Randall
- , Amit P. Khandhar
- , Kyle Krieger
- , Tien Ying Hsiang
- , Michael Gale
- , Peter Berglund
- , Deborah Heydenburg Fuller
- , Heinz Feldmann
- , Jesse H. Erasmus
Research output: Contribution to journal › Article › peer-review
28
Link opens in a new tab
Scopus
citations